Search

Your search keyword '"Itakura, Jun"' showing total 647 results

Search Constraints

Start Over You searched for: Author "Itakura, Jun" Remove constraint Author: "Itakura, Jun"
647 results on '"Itakura, Jun"'

Search Results

1. Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease

2. Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

5. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup

6. Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice

8. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study

10. Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis.

14. Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

15. Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection

16. Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic cancer after pancreatectomy

17. Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B

18. Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test

20. Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy

21. Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

22. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy

25. L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis

26. Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan

27. Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites

30. Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy

31. The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy

32. Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

35. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study

36. Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice

37. Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

38. Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy

40. Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis

41. Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan

42. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease

43. Identifying dilated vessels by magnifying endoscopy with narrow-band imaging : prediction of minute submucosal invasion in two cases of early gastric cancer

44. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin–bilirubin grade

45. Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients

46. Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer Progression

48. Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients

Catalog

Books, media, physical & digital resources